Castle Biosciences Inc.

NASDAQ: CSTL · Real-Time Price · USD
20.09
0.27 (1.36%)
At close: Aug 15, 2025, 3:59 PM
19.70
-1.94%
After-hours: Aug 15, 2025, 06:34 PM EDT

Castle Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
18.25M -57.47M -67.14M -31.29M
Depreciation & Amortization
16M 12.33M 10.54M 3.41M
Stock-Based Compensation
50.32M 51.22M 36.32M 21.74M
Other Working Capital
3.08M 6.55M 7.31M 384K
Other Non-Cash Items
-6.97M -4.86M -19.5M 33.04M
Deferred Income Tax
1.4M -223K -1.88M -8.74M
Change in Working Capital
-14.13M -6.63M -7K -4.1M
Operating Cash Flow
64.87M -5.63M -41.66M -18.98M
Capital Expenditures
-28.33M -13.62M -5.63M -3.48M
Cash Acquisitions
18K n/a -26.97M -63.18M
Purchase of Investments
-205.73M -189.07M -134.69M n/a
Sales Maturities Of Investments
183.9M 186.5M n/a n/a
Other Investing Acitivies
n/a 13K 742K 10K
Investing Cash Flow
-50.14M -16.18M -166.54M -66.66M
Debt Repayment
9.9M -142K -122K -8K
Common Stock Repurchased
n/a -5.13M -1.69M -781K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-5.78M -2.16M 1.64M 5.43M
Financial Cash Flow
6.14M -2.3M 1.51M 5.42M
Net Cash Flow
20.87M -24.11M -206.69M -80.22M
Free Cash Flow
36.54M -19.25M -47.29M -22.47M